Lexaria Bioscience Corp. LEXX
4.51 USD -0.17 (-3.72%)
Nov 11, 2026, 11:29 AM EST
4.50 Day range 4.67
2.43 52-week range 21.60
- YTD
- -51.34%
- 1 year
- -73.18%
Revenue & Expenses
Revenue by
Latest period ending Aug 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Aug 31, 2025 | FY 2024 Aug 31, 2024 | FY 2023 Aug 31, 2023 | FY 2022 Aug 31, 2022 | FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| 705.92K | 464.28K | 226.21K | 255.40K | 722.74K | |
| 703.20K | 459.46K | 194.71K | 183.56K | 547.39K | |
| -11.88M | -5.75M | -6.53M | -6.62M | -4.16M | |
| -11.90M | -5.80M | -6.66M | -7.38M | -4.19M | |
| -9.90 | -7.00 | -15.20 | -18.60 | -14.20 |
Balance sheet
| Fiscal year | FY 2025 Aug 31, 2025 | FY 2024 Aug 31, 2024 | FY 2023 Aug 31, 2023 | FY 2022 Aug 31, 2022 | FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| 1.80M | 6.50M | 1.35M | 5.81M | 10.92M | |
| 4.18M | 8.87M | 3.08M | 7.83M | 13.27M | |
| 1.57M | 1.21M | 403.91K | 201.44K | 203.26K | |
| 109.32K | 137.37K | 163.97K | 49.99K | 97.32K | |
| 2.99M | 8.04M | 3.04M | 7.95M | 13.27M |
Cash flow
| Fiscal year | FY 2025 Aug 31, 2025 | FY 2024 Aug 31, 2024 | FY 2023 Aug 31, 2023 | FY 2022 Aug 31, 2022 | FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| -10.45M | -4.96M | -5.88M | -4.88M | -3.99M | |
| -243.02K | -188.60K | -169.61K | -180.64K | 193.88K | |
| 6.05M | 10.32M | 1.59M | -44.60K | 13.42M | |
| -24.65K | -43.01K | -33.75K | -49.19K | 0 | |
| -4.70M | 5.15M | -4.46M | -5.10M | 9.62M |